youtube_live
Q3 2026 earnings • released • EPS miss -19.01% • Revenue beat +65.26%
See resultschevron_right
AKTS:NASDAQ
Aktis Oncology Inc
$16.62
arrow_upward
+2.09%(+0.34) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTS...
Open
$16.33
High
$16.73
Low
$15.76
Mkt. cap
893.27M
Avg. vol.
363.85K
Volume
244.55K
52-wk high
$34.19
52-wk low
$13.96
EPS
-$1.42
Shares outstanding
53.75M
No. of employees
79
Open
$16.33
High
$16.73
Low
$15.76
Mkt. cap
893.27M
Avg. vol.
363.85K
Volume
244.55K
52-wk high
$34.19
52-wk low
$13.96
EPS
-$1.42
Shares outstanding
53.75M
No. of employees
79
News stories
From web sources and news partners
TradingKey
·
8 hours ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
7 hours ago
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
The Motley Fool
·
18 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
About Aktis Oncology Inc
CEO-
Employees79
Founded2020
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteaktisoncology.com